UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

The Journal of pathology, 2008-01, Vol.214 (1), p.17-24

2008

Link zum Volltext

Verfügbarkeit prüfen

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

Annals of oncology, 2017-11, Vol.28 (11), p.2768-2772

2017

Link zum Volltext

Verfügbarkeit prüfen

Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18

Journal of molecular histology, 2021-12, Vol.52 (6), p.1257-1264

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial

Annals of oncology, 2018-10, Vol.29, p.viii703-viii703

2018

Link zum Volltext

Verfügbarkeit prüfen

Five-year results of the prospective Phase III WSG PlanB trial confirm prognostic impact of 21-Gene Recurrence Score in high-risk HR+/HER2− early breast cancer (EBC) patients with 1-3 involved lymph nodes

Breast (Edinburgh), 2017-03, Vol.32, p.S93-S93

2017

Link zum Volltext

Verfügbarkeit prüfen

1937 Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX®: First prospective survival results from the WSG phase III planB trial

European journal of cancer (1990), 2015-09, Vol.51, p.S311-S311

2015

Link zum Volltext

Verfügbarkeit prüfen

P231 Luminal subtypes vs. early Ki-67 response and Oncotype DX® in early breast cancer: WSG-ADAPT study

Breast (Edinburgh), 2015-03, Vol.24, p.S104-S105

2015

Link zum Volltext

Verfügbarkeit prüfen

Transmurale Nekrose des Fundus uteri nach septischem Abort – ein Fallbericht

Geburtshilfe und Frauenheilkunde, 2022, Vol.82 (10)

2022

Link zum Volltext

Verfügbarkeit prüfen

HPV RNA analyses in sentinel and peripheral lymph nodes as potential diagnostic tool for metastatic cervical cancer

Geburtshilfe und Frauenheilkunde, 2022, Vol.82 (10)

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells

British journal of cancer, 2003-11, Vol.89 (9), p.1714-1721

2003

Link zum Volltext

Verfügbarkeit prüfen

Differential impact of prognostic parameters in hormone receptor-positive lobular early breast cancer in the WSG PlanB trial

European journal of cancer (1990), 2020-10, Vol.138, p.S1-S1

2020

Link zum Volltext

Verfügbarkeit prüfen

LBA24 Multiparametric prognostic score in early HR+/HER2- breast cancer: Impact of recurrence score, clinical-pathological factors, gene mutations and histology

Annals of oncology, 2023-10, Vol.34, p.S1262-S1263

2023

Link zum Volltext

Verfügbarkeit prüfen

164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results

Annals of oncology, 2020-09, Vol.31, p.S306-S306

2020

Link zum Volltext

Verfügbarkeit prüfen

Ectopia of mammary tissue

Der Pathologe, 2018-09, Vol.39 (5), p.398-401

2018

Link zum Volltext

Verfügbarkeit prüfen

LBA14 Impact of age, recurrence score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

Annals of oncology, 2022-09, Vol.33, p.S1382-S1383

2022

Link zum Volltext

Verfügbarkeit prüfen

LBA14 De-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs trastuzumab+ET in early HR+/HER2+ breast cancer (BC): ADAPT-TP survival results

Annals of oncology, 2020-09, Vol.31, p.S1146-S1146

2020

Link zum Volltext

Verfügbarkeit prüfen

LBA13 Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial

Annals of oncology, 2021-09, Vol.32, p.S1285-S1285

2021

Link zum Volltext

Verfügbarkeit prüfen

Histological grading of breast cancer

Der Pathologe, 2016-07, Vol.37 (4), p.328

2016

Link zum Volltext

Verfügbarkeit prüfen

ADAPTcycle – adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer

Breast (Edinburgh), 2019-03, Vol.44, p.S133

2019

Link zum Volltext

Verfügbarkeit prüfen

P342 - ADAPTcycle – adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer

Breast (Edinburgh), 2019-03, Vol.44, p.S133-S133

2019

Link zum Volltext

Verfügbarkeit prüfen

120TiP Premenopausal women with breast cancer optimally treated with OFS (PROOFS)

ESMO open, 2023-05, Vol.8 (1), p.101344, Article 101344

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Englisch
(65)
Deutsch
(21)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Life Sciences & Biomedicine
(30)
Humans
(19)
Pathology
(16)
Female
(15)
Oncology
(12)
Breast Cancer
(9)
Breast Neoplasms - Pathology
(8)
Prognosis
(8)
Biological And Medical Sciences
(6)
Tumor Cells, Cultured
(6)
Breast Neoplasms - Genetics
(5)
Immunohistochemistry
(5)
Medical Sciences
(5)
Medicine
(5)
Medicine & Public Health
(5)
Middle Aged
(5)
Biomarkers, Tumor - Analysis
(4)
Breast - Pathology
(4)
Hematology, Oncology And Palliative Medicine
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Der Pathologe
(15)
Annals Of Oncology
(13)
Cancer Research
(13)
Breast
(6)
European Journal Of Cancer
(3)
Npj Breast Cancer
(3)
Esmo Open
(2)
Plos One
(2)
The Journal Of Pathology. Clinical Research
(2)
Annals Of The New York Academy Of Sciences
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial

Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18

Prognostic impact of anthracyclines and immune/proliferation markers in TNBC according to pCR after de-escalated neoadjuvant chemotherapy with 12 weeks of nab-paclitaxel/carboplatin or gemcitabine: Survival results of WSG-ADAPT-TN phase II trial

De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR− phase II trial: efficacy, safety, and predictive markers for 12weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel

Five-year results of the prospective Phase III WSG PlanB trial confirm prognostic impact of 21-Gene Recurrence Score in high-risk HR+/HER2− early breast cancer (EBC) patients with 1-3 involved lymph nodes

1937 Clinical impact of risk classification by central/local grade or luminal-like subtype vs. Oncotype DX®: First prospective survival results from the WSG phase III planB trial

P231 Luminal subtypes vs. early Ki-67 response and Oncotype DX® in early breast cancer: WSG-ADAPT study

Transmurale Nekrose des Fundus uteri nach septischem Abort – ein Fallbericht

HPV RNA analyses in sentinel and peripheral lymph nodes as potential diagnostic tool for metastatic cervical cancer

Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells

Differential impact of prognostic parameters in hormone receptor-positive lobular early breast cancer in the WSG PlanB trial

LBA24 Multiparametric prognostic score in early HR+/HER2- breast cancer: Impact of recurrence score, clinical-pathological factors, gene mutations and histology

164MO Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance: WSG-ADAPT HR+/HER2- translational results

Ectopia of mammary tissue

LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial

LBA14 Impact of age, recurrence score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

LBA14 De-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs trastuzumab+ET in early HR+/HER2+ breast cancer (BC): ADAPT-TP survival results

LBA13 Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer: WSG ADAPT TP trial

Histological grading of breast cancer

ADAPTcycle – adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer

P342 - ADAPTcycle – adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate risk HR+/HER2- early breast cancer

120TiP Premenopausal women with breast cancer optimally treated with OFS (PROOFS)

Suchergebnisse filtern